Barclays PLC Buys 67,016 Shares of Nu Skin Enterprises, Inc. (NYSE:NUS)

Barclays PLC grew its position in shares of Nu Skin Enterprises, Inc. (NYSE:NUSFree Report) by 363.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 85,437 shares of the company’s stock after acquiring an additional 67,016 shares during the quarter. Barclays PLC owned 0.17% of Nu Skin Enterprises worth $629,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Canada Pension Plan Investment Board bought a new stake in Nu Skin Enterprises during the second quarter worth $47,000. Dark Forest Capital Management LP bought a new stake in shares of Nu Skin Enterprises during the 2nd quarter worth $106,000. Covestor Ltd raised its stake in shares of Nu Skin Enterprises by 110.9% during the 3rd quarter. Covestor Ltd now owns 10,140 shares of the company’s stock worth $75,000 after purchasing an additional 5,333 shares during the period. Gladius Capital Management LP bought a new position in Nu Skin Enterprises during the third quarter valued at about $77,000. Finally, Versor Investments LP bought a new position in Nu Skin Enterprises during the third quarter valued at about $86,000. Institutional investors own 82.84% of the company’s stock.

Wall Street Analyst Weigh In

NUS has been the topic of a number of research analyst reports. DA Davidson dropped their target price on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a research note on Friday, December 20th. StockNews.com upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Monday, November 11th. Finally, Citigroup decreased their target price on Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating for the company in a research report on Tuesday, October 22nd.

Check Out Our Latest Report on Nu Skin Enterprises

Nu Skin Enterprises Price Performance

Shares of NYSE:NUS opened at $6.94 on Friday. The company has a 50-day moving average price of $7.18 and a two-hundred day moving average price of $8.02. Nu Skin Enterprises, Inc. has a twelve month low of $5.95 and a twelve month high of $19.30. The company has a quick ratio of 1.20, a current ratio of 1.93 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $345.14 million, a PE ratio of -3.35 and a beta of 1.19.

Nu Skin Enterprises Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, December 11th. Investors of record on Friday, November 29th were paid a $0.06 dividend. The ex-dividend date of this dividend was Friday, November 29th. This represents a $0.24 dividend on an annualized basis and a yield of 3.46%. Nu Skin Enterprises’s dividend payout ratio is -11.59%.

About Nu Skin Enterprises

(Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

See Also

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUSFree Report).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.